Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors.
about
A protein interaction network for Ecm29 links the 26 S proteasome to molecular motors and endosomal componentsProteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradationREGgamma proteasome mediates degradation of the ubiquitin ligase Smurf1A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons.Intracellular Dynamics of the Ubiquitin-Proteasome-SystemProteasome inhibitors in progressive renal diseasesStructural Models for Interactions between the 20S Proteasome and Its PAN/19S ActivatorsStructure of a Blm10 Complex Reveals Common Mechanisms for Proteasome Binding and Gate OpeningBlm10 binds to pre-activated proteasome core particles with open gate conformation.Blm10 protein promotes proteasomal substrate turnover by an active gating mechanismProteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination.Proteasome-mediated processing of Nrf1 is essential for coordinate induction of all proteasome subunits and p97The ubiquitin proteasome system in glia and its role in neurodegenerative diseasesRegulators of the proteasome pathway, Uch37 and Rpn13, play distinct roles in mouse developmentMisfolding of proteins with a polyglutamine expansion is facilitated by proteasomal chaperonesAlterations in cytoskeletal and immune function-related proteome profiles in whole rat lung following intratracheal instillation of heparinChronic ethanol feeding affects proteasome-interacting proteinsEDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis.Role of proteasomes in disease.Aging is not associated with proteasome impairment in UPS reporter mice.Quantitative proteome analysis of the 20S proteasome of apoptotic Jurkat T cells.Proteasome inhibitors and cardiac cell growthMolecular mechanisms of proteasome plasticity in aging.Molecular and cellular roles of PI31 (PSMF1) protein in regulation of proteasome function.MDM2 promotes proteasomal degradation of p21Waf1 via a conformation change.Characterization of the Brain 26S Proteasome and its Interacting ProteinsAssembly, structure, and function of the 26S proteasome.ATP binding and ATP hydrolysis play distinct roles in the function of 26S proteasome.Comparative analysis of REG{gamma} expression in mouse and human tissuesInterspecies translation of disease networks increases robustness and predictive accuracy.Proteasome activator REGgamma enhances coxsackieviral infection by facilitating p53 degradation.The 19S proteasome activator promotes human cytomegalovirus immediate early gene expression through proteolytic and nonproteolytic mechanisms.Altered composition of liver proteasome assemblies contributes to enhanced proteasome activity in the exceptionally long-lived naked mole-ratMolecular characterization of the evolution of phagosomes.Proteasome activator PA200 is required for normal spermatogenesis.Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival.Proteasomal degradation of Sfp1 contributes to the repression of ribosome biogenesis during starvation and is mediated by the proteasome activator Blm10.Decreased activity of the 20S proteasome in the brain white matter and gray matter of patients with multiple sclerosis.Poly-Ub-substrate-degradative activity of 26S proteasome is not impaired in the aging rat brain.
P2860
Q24294383-FEC46F4B-0D81-4911-8944-489F9659D5C9Q24319027-0126CA27-940C-4A22-BFC3-BC81AE7914EFQ24336438-BC70D483-92EB-443B-A082-02E6C9D4A342Q24529893-FAAE8318-C1E2-4A6B-9512-7400E8E3D14AQ26784629-8F651BBA-AE00-49D7-A64E-4C491B1FD71BQ27011485-68CDDA5B-2500-42AA-B7D4-6CDF53542851Q27658058-11108DDB-59E2-4873-B810-410257895840Q27660222-00E25663-BDB6-4BA8-84EE-926EADD2CC48Q27929843-41A9ABAA-D1AB-4537-A37F-F53D067076C9Q27931319-356F72DC-8558-46D4-AC97-BFC52898A2EBQ27932737-9DE2D4BB-5FDD-47A2-8C8A-7C27CC3A11E7Q28243388-5FF32A2C-949D-48D7-9295-90B3F88B0CA1Q28391948-68D40848-F255-4992-BC61-449A085FBF12Q28505259-0822826F-9ABD-48D6-B6EF-561E1A1E1AE6Q28569827-02B3EF16-B5F2-4B2A-8B6F-05AF45FA81ACQ28576505-27D7BF58-161B-48A5-8E9F-EF94D175C3AAQ28582843-40161A7B-38D2-47D5-8952-943703501A5EQ30405442-0955B96D-A264-403F-91B0-ACC1D0C0A4EDQ31052140-4B8E49E6-DA88-4C4E-A2CA-6E7B18B7106DQ33307877-A6A51933-1DC0-499A-A826-53580D8442C9Q33466066-71E151DC-E126-409E-A162-AF1F54A6EDD6Q33549232-FC4D6E72-5269-4089-B279-CF4868E6F8F8Q33554490-65FCF9EC-590F-4544-BDDD-EEADBC698E8BQ33770237-5BCFEC9E-D807-4494-A6A0-EEFE9037006DQ33792867-25D3DEE2-3F60-4D2A-83E3-69DECDB437D1Q33897779-B76EF9E1-6FC6-4318-A5DA-1C8760D0922FQ33980033-2B1A5417-9F24-440D-BE46-DA1343111B2DQ33988314-CDFA737B-D25C-4887-AF6F-F917578E82F5Q33999948-44DB05BB-409D-4E15-BC6C-35FE40F5690FQ34042286-DC0C215E-194B-47F6-AFBD-3BEA004A8F20Q34071347-9D1DE515-747D-4FC3-A1CF-8648905BFE1DQ34190751-97DED7C7-BD6D-4678-8796-B3271BE1A449Q34261453-B3652F18-99B6-47D7-BFBB-07C9541DEBF6Q34261611-158A4C7A-3397-4EF7-8259-2DA450EC27BAQ34344310-A401DAE2-E9B6-4C47-8513-DC80D13B2D59Q34563112-8977955E-925A-4A53-8668-1E4F4ABC5ED0Q34606461-427F212B-B71E-4387-8BBB-062FDED80360Q34611628-2D3BB6C9-137C-4FF2-8724-CBBF65B22EC1Q34663500-A7D14C28-DAEF-421A-B03F-850935FE67EEQ34718525-085E7365-62B1-4926-9FF4-500BC53D2F21
P2860
Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Mobilizing the proteolytic mac ...... ome activators and inhibitors.
@ast
Mobilizing the proteolytic mac ...... ome activators and inhibitors.
@en
type
label
Mobilizing the proteolytic mac ...... ome activators and inhibitors.
@ast
Mobilizing the proteolytic mac ...... ome activators and inhibitors.
@en
prefLabel
Mobilizing the proteolytic mac ...... ome activators and inhibitors.
@ast
Mobilizing the proteolytic mac ...... ome activators and inhibitors.
@en
P1476
Mobilizing the proteolytic mac ...... ome activators and inhibitors.
@en
P2093
Christopher P Hill
Martin Rechsteiner
P356
10.1016/J.TCB.2004.11.003
P577
2005-01-01T00:00:00Z